Herein, we present two patients with type 1 diabetes treated with CSII in whom peak action of breakfast insulin boluses is too delayed to achieve adequate postprandial glucose control but causes late episodes of hypoglycemia. This evidence concerns the gene INS and Hypoglycemia.